Russell Health Recognized as One of The “10 Most Promising Biotech Startups 2020”
StartUp City Magazine recognizes Russell Health, Inc. as one of the "10 Most Promising Biotech Startup 2020". With Russell Health's innovative regenerative medicine product lines, StartUp City Magazine recognizes Russell Health for its relentless pursuit of safe, effective and innovative regenerative medicine products. Recipients of this honor are decided by a distinguished panel of biotechnology…
Keep Reading
Medicare to Cover All FDA-approved Covid-19 Vaccines
The Centers for Medicare and Medicaid Services released an interim final rule yesterday (10/28) stating that Medicare will cover vaccines that receive FDA authorization. This includes vaccines that receive emergency use authorization, at no cost to beneficiaries. There is an international race between drug development companies to create a safe Covid-19 vaccine. Previously reported by…
Keep Reading
SUMMARY: Immunomodulatory Properties of Amniotic Membrane Derivatives and Their Potential in Regenerative Medicine
Below is a summary of an article published in June 2020 by Current Diabetes Reports as part of the Topical Collection on Immunology, Transplatation and Regenerative Medicine. Russell Health, Inc. distributes amniotic membrane products, which are considered Stem Cell Recruitment Therapy® products. The amniotic membrane is the innermost layer of the human placenta and encloses…
Keep Reading
How to Adapt Your Practice Amid The COVID-19 Pandemic
We at Russell Health would like to share an article written on April 20, 2020 by Todd Petersen published by Dermatology Times. The coronavirus has created a challenging environment for all private healthcare practices. After all, most are suffering through significant patient visit declines, or have shut down altogether. The adage by Sir Winston Churchill, "Never waste…
Keep Reading
Congratulations Dr. Yula Indeyeva, MCS Maverick Award Winner!
Congratulations to our Stem Cell Recruitment Cosmetics' Medical Advisor, Dr. Yula Indeyeva, for presenting on the Stem Cell Recruitment Facial™ and winning the Miami Cosmetic Surgery Maverick Award! The Maverick Award recognizes one speaker in each scientific session whose ideas and presentation are the most progressive, out of the box and likely to make a…
Keep Reading
Harvard Review of Growth Factor Delivery Systems
"Growth factors are critical signalling molecules that instruct cells during development, and one may achieve tissue regeneration in the adult by enabling control over growth factor delivery." -K. Lee et al., Harvard University Figure 4. Sophisticated material systems capable of using growth factors to programme native cells. Polymer systems can be functionalized to recruit specific subsets of cells, where the cells are programmed to…
Keep Reading
Engineered Extracellular Matrix Scaffolds: Facilitate Healing, Tissue Regeneration
Engineered Extracellular Matrix Scaffolds Facilitate Healing, Tissue Regeneration Studies have shown that implanted extracellular matrix scaffolds (such as processed amniotic fluid and placental tissue) with inductive niches can facilitate healing and differentiation of host cells, thereby enhancing regeneration of several cell and tissue types. These extracellular matrix scaffolds provide cells with "guidance cues" for directional migration and spacial organization resulting…
Keep Reading
FDA’s Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use
As highlighted last year with the release of the FDA’s comprehensive regenerative medicine policy framework, including the FDA’s final guidance (Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use), the FDA intends to apply a risk-based approach to enforcement of cell-based regenerative medicine products, taking into account how products…
Keep Reading